MIS Trends 2014: Improving Visualization

Innovation is driving healthy growth in the multibillion-dollar market for minimally invasive surgical products as manufacturers develop new laparoscopic visualization systems and advanced surgical tools with robotic-like features designed to enable more complex procedures to be performed via a minimally invasive approach.

Manufacturers of minimally invasive surgical (MIS) products are developing new laparoscopic visualization systems and advanced surgical tools designed to offer some of the benefits of robotic surgery without the challenges posed by current robotic platforms. These companies are counting on such hybrid solutions to provide a technological and economic middle ground between traditional laparoscopy and robotic surgery and enable more complex procedures to be performed via a minimally invasive approach. Advances in imaging, such as three-dimensional (3D) high-definition (HD) laparoscopy systems (3D HD), fluorescence imaging, and image guidance, along with new handheld tools and energy devices designed to enhance dexterity, maneuverability, rotation, precision, and ergonomics will continue to drive growth in the multibillion-dollar MIS products market. Manufacturers are also driving growth by targeting underpenetrated and emerging markets, particularly in Asia and Latin America, and by focusing education, sales, and product development efforts on underserved clinical areas with good potential for increasing MIS adoption in gynecologic, thoracic, hepatobiliary, pancreatic, colorectal, oncologic, and bariatric surgery. (SeeAlso see "Trends In MIS, Part I: Pushing Surgical Boundaries" - Medtech Insight, 25 May, 2012..)

In part one of this two-part series, Medtech Insight covers the latest advances in laparoscopic visualization, and highlights the trends...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Asia

Industry Execs Talk Tariff Turbulence During MD&M East

 

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

India-UK Free Trade Agreement Sets Stage For Medtech Growth, But Industry Demands Safeguards

 
• By 

Announced after three years of negotiation, the FTA eliminates tariffs on 99% of Indian product types, covering nearly all trade value, and reduces tariffs on 90% of UK products. Although not yet formally signed, the deal is being positioned by the Indian government as “transformative,” with an estimated economic impact of $6.4bn for the UK alone by 2040.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Medical Devices Not The Focus Of FDA’s Plans To Step Up Foreign Inspections, Expert Says

 

The US FDA recently announced plans to carry out more unannounced inspections of foreign facilities. But those inspections will primarily target drug producers, with less attention and resources allocated to those making devices.

More from Geography

FDA Drops Package Labeling Guidance For Hernia Mesh Manufacturers

 

The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.

Medtechs Wait For Dividend As UK Spending Review Prioritizes Healthcare And NHS

 
• By 

Increased support for NHS services and delivery infrastructure announced in the 11 June government spending review by chancellor of the exchequer Rachel Reeves could boost inward investment and offer new market opportunities for medtechs.

UK Healthtech Center Of Excellence Given Key MHRA Digital Regulation Role

 
• By 

Ahead of the 11 June UK spending review and its anticipated funding uplift for healthcare and life sciences, the MHRA announced an expansion of its digital expertise by creating a dedicated hub in Leeds, a renowned center of medtech excellence.